Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: APLLTD and BSE: 533573 (ISIN INE901L01018).
It has a market capitalisation of ₹15,534 crore, a last close of ₹790.35 on 2026-10-19, a one-year return of -15.8%.
Valuation: a price-to-earnings ratio of 22.53x, a price-to-book ratio of 2.74x, a dividend yield of 1.5%.
Profitability: return on equity of 12.3%, return on capital employed of 13.7%, an operating margin of 15.0%.
Growth: sales growth of 9.1% a year over three years, net profit growth of 25.2% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.24x, promoter holding of 69.9%.
| Metric | Value |
|---|---|
| Market capitalisation | 15,534 |
| Last close | ₹790.35 |
| P/E (TTM) | 22.53x |
| P/B | 2.74x |
| Dividend yield | 1.5% |
| ROE (FY) | 12.3% |
| ROCE (FY) | 13.7% |
| Operating margin (TTM) | 15.0% |
| Sales growth, 3-year CAGR | 9.1% |
| Profit growth, 3-year CAGR | 25.2% |
| Debt / equity | 0.24x |
| Promoter holding | 69.9% |
| 1-year return | -15.8% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means